
Invitae Corporation NVTA
Quarterly report 2023-Q3
added 05-23-2026
Invitae Corporation Operating Cash Flow 2011-2026 | NVTA
Annual Operating Cash Flow Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -493 M | -560 M | -299 M | -145 M | -92.2 M | -98 M | -76.3 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -76.3 M | -560 M | -252 M |
Quarterly Operating Cash Flow Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -156 M | -89.3 M | -34.4 M | - | -411 M | -282 M | -148 M | - | -384 M | -219 M | -89.5 M | - | -185 M | -123 M | -62.4 M | - | -97.8 M | -61.1 M | -28.4 M | - | -76.7 M | -58.7 M | -32.9 M | - | -66.7 M | -41.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -28.4 M | -411 M | -132 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 206.11 | 0.77 % | $ 22.9 B | ||
|
Celcuity
CELC
|
-153 M | $ 87.19 | -5.84 % | $ 4.08 B | ||
|
Fulgent Genetics
FLGT
|
-102 M | $ 19.0 | 2.7 % | $ 585 M | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 4.16 | -7.56 % | $ 5.53 M | ||
|
Castle Biosciences
CSTL
|
64.3 M | $ 21.22 | 0.66 % | $ 615 M | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-24.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
-185 M | $ 131.65 | 1.18 % | $ 16.5 B | ||
|
CareDx, Inc
CDNA
|
42 M | $ 22.89 | 0.62 % | $ 1.22 B | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
1.04 B | $ 150.72 | -0.73 % | $ 11.8 B | ||
|
Check-Cap Ltd.
CHEK
|
-46 K | - | - | $ 9.42 M | ||
|
Illumina
ILMN
|
1.08 B | $ 165.92 | 3.68 % | $ 25.7 B | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 1.79 | 2.87 % | $ 7.92 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-9.68 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-460 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
390 M | $ 101.92 | 1.94 % | $ 6.88 B | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 190.0 | 0.08 % | $ 9.42 B | ||
|
Medpace Holdings
MEDP
|
713 M | $ 472.58 | 1.24 % | $ 13.6 B | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
956 M | $ 1 142.7 | -1.74 % | $ 23.6 B | ||
|
NeoGenomics
NEO
|
5.23 M | $ 11.69 | 2.19 % | $ 1.5 B | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 4.61 | 1.54 % | $ 427 M | ||
|
National Research Corporation
NRC
|
26.4 M | $ 21.13 | 6.99 % | $ 473 M | ||
|
Natera
NTRA
|
215 M | $ 217.87 | -2.22 % | $ 29.8 B | ||
|
Pacific Biosciences of California
PACB
|
-111 M | $ 1.39 | 1.47 % | $ 417 M | ||
|
Personalis
PSNL
|
-74.9 M | $ 10.01 | 2.62 % | $ 893 M | ||
|
Senseonics Holdings
SENS
|
-59.1 M | $ 7.37 | -0.81 % | $ 308 M | ||
|
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
46.8 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.03 | -1.02 % | $ 4.66 M | ||
|
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 68.85 | -1.73 % | $ 4.12 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 273.95 | 1.01 % | $ 22.8 B | ||
|
Waters Corporation
WAT
|
653 M | $ 369.51 | -0.44 % | $ 22 B | ||
|
Thermo Fisher Scientific
TMO
|
7.82 B | $ 488.1 | -1.21 % | $ 184 B | ||
|
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.68 | 1.91 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 9.24 | -0.48 % | $ 2 B |